Junctional Epidermolysis Bullosa (LAMB3-Related)

Junctional Epidermolysis Bullosa (JEB) is a group of rare inherited skin disorders characterized by extremely fragile skin that blisters and tears with minimal friction or trauma. The name "junctional" refers to the location of skin separation, which occurs within the lamina lucida of the basement membrane zone—the junction between the outer epidermis and the underlying dermis.

JEB ranges in severity from lethal forms that cause death in infancy to milder forms compatible with a normal lifespan. The severe generalized form (formerly called Herlitz JEB) presents at birth with widespread blistering, granulation tissue around the mouth and nose, and involvement of the respiratory, gastrointestinal, and genitourinary tracts. The milder generalized form has less extensive blistering and better prognosis.

Common features include skin blistering from birth, slow wound healing, scarring alopecia (hair loss with scarring), dental enamel defects, and nail abnormalities. Chronic wounds can become infected and may increase the risk of squamous cell carcinoma in adulthood. Blisters can also occur in the mouth, esophagus, and other internal surfaces lined with similar epithelium.

LAMB3-related JEB is caused by mutations in the LAMB3 gene, which encodes a component of laminin-332, a protein essential for attaching the epidermis to the underlying tissue. The condition is inherited in an autosomal recessive pattern. Management focuses on wound care, infection prevention, nutritional support, and addressing complications. Gene therapy research offers hope for future treatments.

NutraHacker examines the following gene related to Junctional Epidermolysis Bullosa:

• LAMB3

For more information about your own genetic profile as related to Junctional Epidermolysis Bullosa, please check out our NutraHacker Carrier Status and Drug Response Report.

Or to get going without any further delay, upload raw DNA data and find out more about your carrier status today.